Does Rallies track congressional trades in PODD?

Yes. Rallies tracks politician and congressional stock disclosures for PODD, including reported purchases, sales, dates, owners, and trade amounts when available.

Is PODD research on Rallies investment advice?

No. Rallies provides research, data, and educational context for PODD. It does not provide personalized investment advice.

PODD (Insulet Corporation) Stock Analysis - Politician Trades

Insulet Corporation (PODD) is a publicly traded Healthcare sector company. As of May 21, 2026, PODD trades at $157.13 with a market cap of $10.56B and a P/E ratio of 36.47. PODD moved +1.29% today. Year to date, PODD is -44.77%; over the trailing twelve months it is -52.18%. Its 52-week range spans $145.59 to $354.88. Analyst consensus is buy with an average price target of $262.52. Rallies surfaces PODD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Which politicians traded PODD stock?

Recent politician trading activity in PODD includes disclosures from Tina Smith, Markwayne Mullin, Markwayne Mullin, and Markwayne Mullin. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.

PODD Key Metrics

Key financial metrics for PODD
Metric	Value
Price	$157.13
Market Cap	$10.56B
P/E Ratio	36.47
EPS	$4.30
Dividend Yield	0.00%
52-Week High	$354.88
52-Week Low	$145.59
Volume	7
Avg Volume	0
Revenue (TTM)	$2.90B
Net Income	$302.80M
Gross Margin	71.01%

Congressional Trades in PODD

Tina Smith sale (partial) PODD on Apr 4, 2024 (amount: $100.00K) for Spouse.
Markwayne Mullin sale PODD on Jan 4, 2024 (amount: $15.00K) for Spouse.
Markwayne Mullin sale (partial) PODD on Dec 22, 2023 (amount: $15.00K) for Self.
Markwayne Mullin purchase PODD on Jan 3, 2023 (amount: $15.00K) for Spouse.

Latest PODD News

Insulet Slides After Q1 Beat as Omnipod 5 Class I Recall Overhang Persists — May 6, 2026
Insulet Q1 Net Income $91.1M, Adjusted EPS $1.42 Tops Estimates — May 6, 2026
Insulet rises as FDA updates Omnipod 5 Class I recall details ahead of earnings — May 1, 2026
Insulet jumps as traders buy ahead of May 6 earnings after 52-week low — Apr 30, 2026
Insulet drops 4% as FDA recall database highlights Omnipod 5 Pod action — Apr 29, 2026

Recent PODD Insider Trades

MINOGUE MICHAEL R bought 2.03K (~$499.85K) on Feb 25, 2026.
McEvoy Ashley bought 4.30K (~$1.03M) on Feb 20, 2026.
Frederick Wayne A.I. sold 1.85K (~$542.51K) on Dec 15, 2025.

PODD Analyst Consensus

23 analysts cover PODD: 0 strong buy, 18 buy, 4 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $262.52.

Common questions about PODD

Which politicians traded PODD stock?: Recent politician trading activity in PODD includes disclosures from Tina Smith, Markwayne Mullin, Markwayne Mullin, and Markwayne Mullin. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.
Does Rallies track congressional trades in PODD?: Yes. Rallies tracks politician and congressional stock disclosures for PODD, including reported purchases, sales, dates, owners, and trade amounts when available.
Is PODD research on Rallies investment advice?: No. Rallies provides research, data, and educational context for PODD. It does not provide personalized investment advice.